secwatch.observer — SEC 8-K summary
======================================

Issuer:     Precipio, Inc. (PRPO)
CIK:        0001043961
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001104659-25-049371
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Precipio Q1 revenue up 43% to $4.9M; adjusted EBITDA loss narrows 92% to $108K
------------------------------------------------------------------------------

- Revenue $4.9M, +43% YoY; overall gross margin improved to 43% from 27%.
- Adjusted EBITDA loss of $108K vs $1.41M loss YoY, a 92% improvement.
- Cash used in operations was $44K vs $667K, improvement of 93%.
- Pathology Services rev +54%, test volume +46%; Products division onboarded 1 new customer, launched 2 panels.
- CEO expects positive operating cash flow in Q2 or Q3; Q2 received ~$400K CARES Act credit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1043961/000110465925049371/0001104659-25-049371-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1043961/000110465925049371/tm2515302d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-049371

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer